Gastroenterology

Serum HBV DNA significantly decreased from week 0-24 in patients treated with entecavir.

The study also showed cost savings for both standard and dose-intensified infliximab.

Both patients and physicians request more time for routine ulcerative colitis appointments.

All NOACs had a lower risk of stroke or SE compared to warfarin, including apixaban, dabigatran, and rivaroxaban.

While effective, liver biopsies are invasive and costly for assessing liver fibrosis.

In part 2 of an interview with HCPLive, Dr. Saxe focuses on the role of microbiota in pain and how concomitant conditions in patients are often nutritionally linked.

Dr. Saxe discusses the role of nutrition in determining levels of inflammation and its potential in treating patients.

Both Crohn’s disease and ulcerative colitis patients had a higher risk of IBD-related readmission and length of stay.

Both vedolizumab and ustekinumab are common treatments for inflammatory bowel disease.

In the study, 5.6% of patients developed a post-operative C difficile infection.

HBeAg loss rate was higher in males and older individuals.

There was not a statistically significant correlation between CDI recurrence and age, gender, previous proton pump inhibitor use, and antibiotic exposure.

There is a need for new antibiotic targets for treating C difficile infections.

The new diet program was compared to the existing front-line therapy of exclusive enteral nutrition.

More than half of DAA prescriptions were prescribed by specialists like gastroenterologist and infectious disease physicians.

Fecal microbiota transplantation could be crucial in the coming years in treating C difficile infections.

IBD patients were less likely to have diets that regularly include vegetables, cereals, breads, and diary.

The cumulative time to curative treatment failure rates of patients who received DAA were 93.6% and 73.2% at 1 and 3 years, respectively.

Italy and the Netherlands both achieved their target HBV control.

Infants between 6-12 months old had the highest prevalence of C difficile detection.

Higher microbiome α diversity had an association with less T2D and lower insulin resistance in individuals without diabetes.

Data show no clinically meaningful difference between insulin glargine-yfgn and insulin glargine in matters of safety, purity and potency.

There was no association found between migraines and Crohn’s disease or ulcerative colitis.

The company expects to continue to study the potential inflammatory bowel disease treatment.

Genotype F was the common genotype found at 5.73 per 1000 person-years of follow-up.